DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics 2016" report to their offering.
This Competitive Intelligence Report about prophylaxis and therapy of Clostridium difficile infections provides a competitor evaluation in the field of new molecules or microorganisms for prevention or treatment of Clostridium difficile infections as of June 2016.
Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of currently active projects in research and development of antibodies, proteins, peptides, vaccines, microorganisms, antibiotics and small molecules for prevention and treatment of Clostridium difficile infections. In addition, the report lists company-specific R&D pipelines of C. difficile vaccines and therapeutics.
Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Key Topics Covered:
1. C. Difficile Vaccines
2. C. Difficile Therapeutics:
- Antibodies
- Microbiome-based
- Anti-Infective Peptides
- Antibiotics
- Others
3. Corporate C. Difficile Vaccines & Therapeutics R&D Pipeline
For more information about this report visit http://www.researchandmarkets.com/research/n8kl2j/competitor
Related Topics: Infectious Diseases Drugs, Vaccines
